Apr. 24 at 1:57 AM
It appears analysts have updated their
$NBIX analysts as NBIX analyst consensus before the
$SLNO acquisition was announced is higher almost exactly by the revenue forecast SLNO management provided NBIX.
The graph compares NBIX 10-year analyst consensus to the 10-year revenue forecast prepared by
$HZNP mgmt/BOD & provided
$AMGN when Amgen acquired HZNP for an enterprise value of
$28.2B. NBIX's market cap is
$13.1B while it appears NBIX's
$2.6B cash balance at 12/31/26 was used to buy SLNO for an EV of
$2.44B.
NBIX management will, eventually, need to consider alternate strategies to enhance shareholder value because NBIX has not traded at revenue multiples consistent with its peers in at least 2 years.
This is not investment advice.
$XBI